Does Ozempic or Wegovy Cause Muscle and Bone Loss? What You Actually Need to Know
Short answer: yes, some of both. But the speed of the weight loss matters more than the medication does, and there's a great deal you can do about it.
Before we go any further — I'm a nutritionist, not a prescriber. Nothing here is advice about whether to take a GLP-1, what dose to be on, or when to come off. That's between you and your doctor. What I can help with is the food and the habits around it, which is the half nobody writes you a prescription for.
How GLP-1s actually work
Ozempic and Wegovy are the same drug — semaglutide. Ozempic is the brand licensed for type 2 diabetes, Wegovy the one licensed for weight loss, and Mounjaro is a different but closely related medication (tirzepatide). People use the names interchangeably, so if you've been told one thing about Ozempic and another about Wegovy, that's why. Without getting too deep into the science, all of them slow down digestion and send signals to the hormones that control hunger.
The net effect is that you end up in a calorie deficit without having to consciously manage one.
I want to be clear about something here, because a lot of writing on this topic drips with judgement. If you've spent twenty years being told your weight is a willpower problem, having that noise switched off is not cheating. It's the first time the playing field has been level. I've written elsewhere about why the willpower story is both wrong and harmful, and GLP-1s are probably the strongest evidence yet that appetite was never a character trait.
There's always an "after"
What this costs in New Zealand — and why there's always an "after"
Here's the part that shapes everything below.
These medications are expensive, and in New Zealand they're not funded for weight loss yet, so it's your money.
Because they're expensive, most people don't stay on them indefinitely. The real-world numbers are stark: somewhere between a third and a half of people are still taking them at one year, and only around 15% at two years.
So the question isn't really "what happens while I'm on this." It's "what happens after" — because for most people there will be an after, and it usually arrives sooner than they expected when they started.
Bone density — the part you don't get back
Most of the conversation about GLP-1s and body composition is about muscle. Bone gets a mention and everyone moves on. That's backwards, because muscle is the recoverable one.
Lose muscle and you can rebuild it. It takes time and it takes work, but the door stays open at 40, at 50, at 70. Bone doesn't offer the same deal. You build the bulk of your skeleton by your late twenties, and from about thirty the job quietly changes from building to holding on.
So it's worth knowing what a big weight loss does to it.
It's the speed, not the drug
This is the most useful thing I've read on the subject. A joint advisory from four American nutrition and obesity bodies put an actual threshold on it: weight loss that is both substantial — 14% of your bodyweight or more — and rapid, over three to four months, is associated with significant bone loss. Slower, more moderate loss preserves bone considerably better.
Read that again, because it's the whole argument in one sentence. The problem isn't the medication. It's the speed.
Which is also why this matters more on a GLP-1 than on an ordinary diet — not because the drug attacks your skeleton, but because it is very good at producing exactly the kind of weight loss that threshold describes. Fast, and a lot of it.
Bone is living tissue and it adapts to load. Carry an extra twenty-five kilos around for a decade and your skeleton has quietly adapted to that. It's not a pleasant way to think about it, but it's true. Take the weight off in four months and the load falls away faster than the bone needs it to.
The same advisory lists what else influences how much you lose: your starting weight, your age, your sex, how active you are, how large the calorie deficit is, and how much protein you're eating. Older people and women lose more.
Does the medication itself make it worse?
Here I'll give you the honest answer rather than the frightening one, because plenty of content online does the opposite.
There is something in the Wegovy label worth knowing about. In the cardiovascular outcomes trial, more hip and pelvis fractures were reported on the medication than on placebo among female patients — 1.0% versus 0.2% — and among patients aged 75 and over, 2.4% versus 0.6%. That's the manufacturer's own prescribing information, not a tabloid headline.
But it isn't the whole picture, and stopping there would be dishonest. Across the wider research on this class of drugs, the fracture findings are inconsistent and they vary by which medication you're talking about. Some GLP-1s have been associated with lower fracture risk than the alternatives. One review found no overall association with increased fracture risk at all.
There's a mechanism argument running the other way, too. Bone cells carry GLP-1 receptors, and in laboratory work these medications appear to nudge bone metabolism in a favorable direction — more building, less breaking down.
One catch, and it matters for anyone reading this. The more encouraging findings come largely from people with type 2 diabetes. In people taking these medications purely for weight loss, the picture looks less favourable. If that's you, the reassuring headlines aren't necessarily about you.
So the fair summary: losing a large amount of weight quickly costs you bone, and that much is well established. Whether the medication adds to it or slightly protects against it is genuinely unsettled, and anyone who tells you they know is ahead of the evidence.
How to prevent muscle loss on Ozempic and Wegovy
In the main semaglutide trial, participants lost an average of 13.6 kg. Of that, 8.3 kg was fat and 5.3 kg was lean body mass — around 38%.
That 38% gets thrown around online as though it's all muscle. It isn't. Lean body mass includes water, glycogen and organ tissue, and a good deal of what disappears early in any weight loss is simply water. When the same advisory separated it out, actual muscle came to roughly 20% of total weight lost.
Still a fifth of everything you lose. Just not the two-fifths the internet will tell you.
And then the line worth building all of this around. Modelling in the same advisory put muscle loss at 10–15% of total weight lost in women and 20–25% in men — followed by five words that matter more than any of the numbers: in the absence of structured strength training.
That's the point. Those figures aren't a fixed cost of the medication. They're what happens by default, to someone who does nothing about it.
Two things fall out of that. First, men lose proportionally more, so if you're a man who's been reading this as a women's issue, it's the other way round. Second, the risk stacks with age, with menopause, with low testosterone and with sitting still — which describes a fair number of the people who reach for a GLP-1 in the first place.
Muscle and bone don't want the same thing
This is the part that changes what you actually do, and it's where most advice goes wrong. You'll read "eat protein and lift weights" as though it solves both problems equally. It doesn't, quite.
Protein is the muscle lever. That's well established, and it's most of the reason the muscle side of this is fixable.
Bone's lever is load. Your skeleton responds to being asked to do something, and that finding is about as consistent as anything in this area — exercise reliably preserves bone through weight loss, and medication plus training beats medication alone. Protein appears to influence bone loss as well, but nobody has established a target for it, and the evidence for loading is far stronger.
So you can't out-protein a bone problem. The food side matters — calcium and vitamin D especially here in New Zealand, when you're barely eating anything at all, and there's a longer list of nutrients that quietly go missing on a suppressed appetite. But for bone specifically, it's the loading that does the work.
If you're wondering why I keep saying loading rather than cardio, that's a whole article of its own.
Why this matters more at 45 than it sounds
Bone loss is silent. No symptom, no ache, nothing on the scales. You find out decades later, and usually you find out through a fracture after a fall that shouldn't have broken anything. Whatever bone you're carrying now is roughly the foundation you're standing on at seventy — the age when a fall stops being embarrassing and starts being the thing that changes your life.
Muscle is the same story in a shorter timeframe. It's the difference between getting off the floor easily at sixty and needing a hand. If the point of all this is being capable for your family rather than smaller in a photograph, both of those are the actual prize, and the number on the scale is just the thing that happens along the way.
Two practical things
Ask your doctor about a baseline DXA scan. Not because you should worry, but because a number now means you can see what's actually happening rather than guessing in five years. The advisory also recommends assessing strength and function before starting — simple things like how many times you can stand out of a chair in thirty seconds. Those are worth writing down, because they'll tell you more than the scales will.
Slow it down if you can. This is the one that sounds like a compromise and isn't. If the bone risk sits above 14% of bodyweight lost in three to four months, then taking the same loss over eight or twelve months is not a failure of ambition — it's the version where you keep more of what you didn't want to lose. and it never was
The bit I'm not going to oversell
Up to two thirds of the weight comes back within a year of stopping. You'll have seen that figure, and it's real. Here's what the advisory also says, which almost nobody quotes: that regain has been observed even when people had conventional nutrition counselling and behavioural therapy alongside. And whether more structured, more intensive support does better has not been tested in controlled trials at all.
So I'm not going to tell you that coaching — mine or anyone else's — will stop the weight coming back. Nobody has shown that. Anyone promising it is selling you something.
What I will tell you is this. The muscle and bone you protect on the way down are yours either way. If the weight does come back, you're carrying it on a stronger frame. If it doesn't, you've got more muscle and better bone density than you would have had. And if you'd rather not find out which by accident, it's worth reading what actually happens when people come off.
The bottom line
If you're paying for a GLP-1, you're already investing in your health, and the return on that plays out over years rather than months. Nobody expects a stock portfolio to pay off in six months. Your body works the same way.
The medication does the hardest part for you — it quiets the noise and takes away the fight with your appetite. What it doesn't do is decide what you're left standing on when the prescription stops. That part is protein, loading, and doing both of them consistently enough that they're still happening in a year — around a job, around kids, on the weeks when everything goes sideways.
That's the part I coach here in Hamilton, Waikato and across New Zealand, and I work alongside your prescriber rather than instead of them.
See how coaching works for GLP-1 users →
Sources
Mozaffarian D, Agarwal M, Aggarwal M, et al. "Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society." Obesity 2025;33(8):1475–1503.
Wegovy (semaglutide) prescribing information, FDA, 2024, Section 6.1.
Gatto A, Liu K, Milan N, Wong S. "The Effects of GLP-1 Agonists on Musculoskeletal Health and Orthopedic Care." Current Reviews in Musculoskeletal Medicine 2025;18(10):469–480.
